DMSIM.BR
Price:
$0.0155
Market Cap:
$23.09M
DMS Imaging SA, a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen. The company is also developing hdm-ASIT+ for the treatment of house dust mite allergy; and pnt-ASIT+ for the treatment of peanut allergy. The company was formerly known as ASIT Biotech S.A. and changed its name to DMS Imaging SA in February 2022. DMS Imaging SA was incorporated in 1997 and is based in Liege, Belgium.
Industry
Biotechnology
IPO Date
2016-05-11
Stock Exchange
BRU
Ticker
DMSIM.BR
According to DMS Imaging S.A.’s latest financial reports and current stock price. The company's current PE Ratio is 0.09. This represents a change of Infinity% compared to the average of 0 of the last 4 quarters.
The mean historical PE Ratio of DMS Imaging S.A. over the last ten years is -5.82. The current 0.09 PE Ratio has changed -247.98% with respect to the historical average. Over the past ten years (40 quarters), DMSIM.BR's PE Ratio was at its highest in in the December 2015 quarter at 0. The PE Ratio was at its lowest in in the December 2015 quarter at 0.
Average
-5.82
Median
-3.10
Minimum
-24.75
Maximum
1.39
Discovering the peaks and valleys of DMS Imaging S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 479.10%
Maximum Annual PE Ratio = 1.39
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -24.75
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.15 | -110.71% |
| 2021 | 1.39 | -159.80% |
| 2020 | -2.32 | 479.10% |
| 2019 | -0.40 | -78.90% |
| 2018 | -1.90 | -51.22% |
| 2017 | -3.89 | -32.67% |
| 2016 | -5.78 | -22.35% |
| 2015 | -7.44 | -42.59% |
| 2014 | -12.96 | -47.64% |
| 2013 | -24.75 | -Infinity% |
The current PE Ratio of DMS Imaging S.A. (DMSIM.BR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.36
5-year avg
-0.68
10-year avg
-5.82
DMS Imaging S.A.’s PE Ratio is greater than Oxurion N.V. (0.03), greater than Celyad Oncology S.A. (-2.63), greater than MDxHealth S.A. (-5.19), greater than Biocartis Group N.V. (-0.27), greater than Greenyard N.V. (-81.43),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0.03 | $369.81K | |
| -2.63 | $18.40M | |
| -5.19 | $85.63M | |
| -0.27 | $27.24M | |
| -81.43 | $355.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DMS Imaging S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DMS Imaging S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is DMS Imaging S.A.'s PE Ratio?
How is the PE Ratio calculated for DMS Imaging S.A. (DMSIM.BR)?
What is the highest PE Ratio for DMS Imaging S.A. (DMSIM.BR)?
What is the 3-year average PE Ratio for DMS Imaging S.A. (DMSIM.BR)?
What is the 5-year average PE Ratio for DMS Imaging S.A. (DMSIM.BR)?
How does the current PE Ratio for DMS Imaging S.A. (DMSIM.BR) compare to its historical average?